DAR ES SALAAM. Tanzania and the United States have signed a five‑year Memorandum of Understanding (MoU) committing more than USD 3.1 billion to strengthen Tanzania’s healthcare system, marking one of the country’s largest bilateral health partnerships in recent years.
The agreement was signed on 1 July 2026 in Dar es Salaam by Minister of Health Mohamed Omary Mchengerwa (MP) and Jeanne Clark, Acting Chargé d’Affaires at the U.S. Embassy in Tanzania. Under the partnership, the Government of Tanzania will invest more than USD 1.8 billion, while the United States intends to provide more than USD 1.3 billion over the next five years.
The programme is designed to strengthen Tanzania’s health system, improve disease surveillance and response, expand digital health infrastructure, and build the country’s capacity to finance and manage essential health services over the long term.
“We did not enter into a specimen‑sharing agreement. Tanzania’s specimens, including those of outbreak, epidemic and pandemic potential, will be tested, stored and governed here in Tanzania,” Minister Mchengerwa said during the signing ceremony, addressing public concerns surrounding the agreement.
A Shift towards Shared Investment
Unlike previous donor‑funded health programmes, the new agreement is structured around joint investment and shared responsibility.
According to a statement from the U.S. Embassy, the partnership reflects both countries’ commitment to strengthening Tanzania’s ability to prevent infectious diseases while building a more self‑sustaining health system.
The agreement is expected to support improvements in laboratory services, public health surveillance, digital health systems, healthcare financing, supply chains, and emergency preparedness.
Why Investors Should Pay Attention
Although the partnership focuses on healthcare, it also presents wider economic opportunities.
The planned investment is expected to increase demand for hospital infrastructure, medical equipment, pharmaceutical products, laboratory technologies, digital health solutions, logistics, and healthcare workforce development.
For companies operating in biotechnology, medical technology, pharmaceuticals, and digital innovation, the programme creates opportunities to participate in projects supporting one of East Africa’s largest health sector investment initiatives.
Outlook
The five‑year partnership signals Tanzania’s commitment to strengthening public services while increasing domestic financing for healthcare.
By combining international support with substantial local investment, the agreement aims to build a more resilient health system capable of responding to future public health challenges while reducing long‑term dependence on external assistance.For investors, the message is clear: beyond improving healthcare outcomes, the Tanzania-U.S. partnership opens new opportunities across pharmaceuticals, medical technology, digital health, healthcare infrastructure, and related industries, reinforcing Tanzania’s position as an expanding market for long‑term investment.
